http://jamanetwork.com/journals/jama/fullarticle/2603417
Acknowledging and Overcoming Nonreproducibility in Basic and Preclinical Research
John P. A. Ioannidis, MD, DSc
JAMA. Published online February 13, 2017.
“Empirical efforts of reproducibility checks performed by industry investigators on a number of top-cited publications from leading academic institutions have shown reproducibility rates of 11% to 25%….
“When results disagree, it is impossible to be 100% certain whether the original experiments, the subsequent experiment, both, or none are correct or wrong. However, the recurrent nonreproducibility and the large diversity in results are concerning. The reproducibility efforts have generally followed high standards, with full transparency and meticulous attention to detail. If those efforts could not reproduce the original findings, it is unlikely that the average laboratory investigator (who probably spends less effort to so meticulously repeat experiments by other scientists) will be able to do this. Furthermore, the reproducibility effort demonstrated that unanticipated outcomes (eg, unforeseen spontaneous regression of tumors) further complicate experiments. Outcomes diverge even with minor modifications in the experimental conditions.”
